Design Intent vs Prescription: Who Decides What in a Veneer Case

A veneer case has three kinds of decisions — what the smile should look like, whether the plan is clinically sound and how to prescribe it, and how to build it — owned by three parties: the patient (guided), the dentist, and the ceramist. Most trouble starts when those roles blur. A smile preview belongs firmly to the first decision: it carries the patient's approved design intent, and it never writes the prescription. Here is the clean version of who owns what, and why keeping the lines sharp produces better cosmetic dentistry.

Who actually decides what in a veneer case?

Three parties, three distinct kinds of decision. The patient decides — with guidance — what they want their smile to look like: this is design intent. The dentist decides whether that look is clinically achievable and safe, and writes the prescription that makes it real. The ceramist decides how to execute that prescription to hit the approved look. When each party owns their layer, cases go smoothly. When the layers bleed into each other — a lab guessing at aesthetics, a preview implying a prescription, a patient dictating clinical specifics — that is when cases come back wrong and relationships fray.

What is “design intent”?

Design intent is the approved look: the shape and arrangement of the teeth, the sense of length and proportion, the character (natural and individual versus uniform and bright), and the shade direction. It is the patient's decision because it is their face — but it is a guided decision, shaped by the dentist's advice on what suits the patient and what is realistic. Design intent is aesthetic, not clinical; it says “this is the smile we're aiming for,” not “this is how to prep the tooth.” A preview is the ideal vehicle for it because the patient reacts to and approves an actual image, turning a vague preference into a recorded target.

What is the prescription — and who owns it?

The prescription is the clinical order: prep design, material selection, shade prescription, any measurements, and the occlusal scheme. It is owned by the dentist, exclusively and always, because it consists of clinical judgements made by a licensed clinician who has examined the patient. The prescription is where “the patient wants a brighter, natural smile” becomes “lithium disilicate veneers, this preparation, this shade against this stump shade, this occlusion.” No patient preference and no software output can write it, because neither carries clinical accountability. The prescription is the bridge from an approved look to a buildable case, and only the dentist can build that bridge.

What does the ceramist decide?

The ceramist owns execution: the layering, the ingot opacity, the staining and characterisation, the contour and glaze — every craft decision that turns a prescription into a restoration that hits the approved look. This is deep expertise, and it is precisely the part that no preview and no measurement can replace. A good dentist hands the ceramist a clear approved look and a sound prescription, then trusts the craft to do what craft does. The ceramist is a partner in the aesthetic result, not a machine executing coordinates.

Where do previews fit?

Previews fit in the first layer only: they carry design intent. A preview shows the patient a believable version of the look under discussion, the patient reacts and approves, and that approved image travels to the lab as a clear statement of the aesthetic target. It is labelled a visualization aid, not a guarantee so everyone reads it as an approved goal, not a promise or a spec. What a preview must never do is drift into the second layer — it does not prescribe, measure, or plan. Keeping it in its lane is what makes it safe and useful at once; the hand-off details are in what a preview should hand your lab.

What goes wrong when the roles blur?

Every characteristic failure of a cosmetic case is a role blurring. A lab left to guess the aesthetics makes a reasonable choice the patient never approved — remake. A preview that prints measurements nudges a clinical decision onto software — liability. A patient allowed to dictate clinical specifics overrides the dentist's judgement — risk. A dentist who skips the aesthetic conversation and just “sends it to the lab” outsources design intent to a technician who never met the patient — mismatch. Sharp roles prevent all four. The clarity is not bureaucracy; it is how accountability and craft each end up in the right hands.

Why must the preview never become the prescription?

Because a preview is not a clinician and cannot carry clinical accountability. The instant a preview starts prescribing — printing measurements, dictating material, specifying prep — it has claimed authority it does not have and cannot answer for, and it has quietly relegated the dentist to a technician executing a machine's plan. That is both an ethical inversion and a regulatory one: a product that outputs clinical orders starts to resemble a medical device that plans treatment. Our own report refuses this outright, printing no measurements at all, for exactly this reason — the argument is in why a simulation is not a treatment plan.

Who owns each decision — the one-look table?

The whole thing fits in a table you could pin above the bench.

The rule underneath it is one line: the preview carries the look, the dentist writes the order, the ceramist does the craft. Across busy Jordan, Iraq, and Saudi cosmetic practices, keeping those three lanes clean is the difference between a case built once and a case built twice. The lab's-eye view is in what your lab wishes you'd send.

Want a preview that carries design intent and stays out of the prescription? book a demo — qualified clinics get a trial set up personally after a short demo.